Facebook Linkedin Twitter
Inside Precision Medicine Scientists Develop Chip-Based Platform to Scan DNA for Off-Target CRISPR Effects

Therapeutics

Hand inserts a molecule into DNA.
Molecular Dx

Scientists Develop Chip-Based Platform to Scan DNA for Off-Target CRISPR Effects

0
The largest sequencing study of osteosarcoma to date has found that 10% of patients with genetic mutation may benefit from IGF1R inhibitors. [vitanovski/Fotolia]
Molecular Dx

Sequencing Study Shows Existing Drugs Could Treat Some Osteosarcoma Patients

0
Cancer immunotherapy research concept
News & Features

DNA Repair Deficiencies Predictive of Immunotherapy Response

0
IntestinesBullsEye
Molecular Dx

Gut Microbiome Diversity Linked to Slower Melanoma Progression

0
Qiagen’s NGS portfolio includes the GeneReader NGS System
Molecular Dx

Qiagen, BMS to Develop Gene Expression Profiles for I-O Therapies Using NGS

0
Amoy Diagnostics (AmoyDx) will partner with CANbridge Life Sciences to develop a companion diagnostic for CANbridge’s lead candidate
Molecular Dx

AmoyDx to Develop CDx for CANbridge Glioblastoma Candidate

0
Brain DNA
Molecular Dx

Agilent Wins Expanded Use in Europe for Opdivo Diagnostic in SCCHN

0
23andMe and drug developer Grünenthal Group will partner on a study intended to glean insights into the genetics of pain.(Source: fred goldstein/Fotolia)
News & Features

23andMe, Grünenthal to Study the Genetics of Pain, with Targeted Treatments in Mind

0
Source: Rita Elena Serda
News & Features

Genomics Brings Heavy Lifting to Immuno-Oncology

Jeffrey S. Buguliskis, Ph.D.
0
lung cancer
News & Features

Complex Genetics Underpin Treatment Resistance to NSCLC

0
1...158159160...163Page 159 of 163

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine